Menu
Consolidated Cash Flow Statement
Show table28.5 KB EXCEL
| € million |
Note |
2015 |
2014 |
| Profit after tax |
|
1,124.1 |
1,164.8 |
| Depreciation / amortization / impairment losses / reversals of impairments |
|
1,510.9 |
1,360.9 |
| Changes in inventories |
|
– 90.0 |
20.9 |
| Changes in trade accounts receivable1 |
|
– 84.5 |
– 94.8 |
| Changes in trade accounts payable |
|
166.5 |
52.8 |
| Changes in provisions |
|
214.7 |
– 341.6 |
| Changes in other assets and liabilities1 |
|
– 636.3 |
533.1 |
| Neutralization of gains / losses on disposal of assets |
|
– 42.0 |
– 9.3 |
| Other non-cash income and expenses |
|
31.8 |
18.7 |
| Net cash flows from operating activities |
➞ 34 |
2,195.2 |
2,705.5 |
| thereof: from discontinued operations |
|
5.6 |
– |
| |
|
|
|
| Payments for investments in intangible assets |
|
– 179.1 |
– 143.3 |
| Payments from the disposal of intangible assets |
|
27.4 |
2.1 |
| Payments for investments in property, plant and equipment |
|
– 513.9 |
– 480.9 |
| Payments from the disposal of property, plant and equipment |
|
8.9 |
14.0 |
| Payments for investments in financial assets |
|
–1 ,740.8 |
– 3,143.3 |
| Payments for acquisitions less acquired cash and cash equivalents |
|
– 13,482.3 |
– 1,419.3 |
| Payments from the disposal of other financial assets |
|
3,858.0 |
3,508.6 |
| Payments from the divestment of assets held for sale |
|
86.0 |
20.9 |
| Net cash flows from investing activities |
➞ 35 |
– 11,935.8 |
– 1,641.2 |
| thereof: from discontinued operations |
|
84.4 |
– |
| |
|
|
|
| Dividend payments to Merck KGaA shareholders |
|
– 129.2 |
– 122.8 |
| Dividend payments to non-controlling interests |
|
– 3.6 |
– 3.1 |
| Dividend payments to E. Merck KG |
|
– 435.0 |
– 382.7 |
| Payments from new borrowings of financial liabilities from E. Merck KG |
|
560.0 |
610.0 |
| Repayments of financial liabilities to E. Merck KG |
|
– 483.6 |
– 470.6 |
| Payments for the acquisition of non-controlling interests |
|
– |
– 351.3 |
| Repayments of bonds |
|
– 1,737.7 |
– |
| Payments from issuance of bonds |
|
5,756.3 |
1,482.9 |
| Payments from new borrowings of other current and non-current financial liabilities |
|
4,106.5 |
322.6 |
| Repayments of other current and non-current financial debt liabilities |
|
– 469.9 |
– 324.5 |
| Net cash flows from financing activities |
➞ 35 |
7,163.8 |
760.5 |
| thereof: from discontinued operations |
|
– |
– |
| |
|
|
|
| Changes in cash and cash equivalents |
|
– 2,576.8 |
1,824.8 |
| Changes in cash and cash equivalents due to currency translation |
|
530.5 |
72.9 |
| Cash and cash equivalents as of January 1 |
|
2,878.5 |
980.8 |
| Cash and cash equivalents as of December 31 |
|
832.2 |
2,878.5 |
| Plus cash and cash equivalents included in assets held for sale |
|
– |
– |
| Cash and cash equivalents as of December 31 (consolidated balance sheet) |
➞ 24 |
832.2 |
2,878.5 |